Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab

Gespeichert in:

Autor*in:	Callahan, Margaret K [verfasserIn] Horak, Christine E Curran, Michael A Hollman, Travis Schaer, David A Yuan, Jianda Lesokhin, Alexander M Kitano, Shigehisa Hong, Quan Ariyan, Charlotte E Busam, Klaus J Feely, William Jure-Kunkel, Maria Grosso, Joseph Simon, Jason S Korman, Alan J Wigginton, Jon M Gupta, Ashok K Zhang, Xiaoling Phillips, Therese Simmons, Pauline Sznol, Mario Wolchok, Jedd D

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2013

Schlagwörter:	Ipilimumab Absolute Lymphocyte Count Tumor Immune Evasion Ipilimumab Monotherapy Serial Peripheral Blood

Anmerkung:	© Callahan et al; licensee BioMed Central Ltd. 2013

Übergeordnetes Werk:	Enthalten in: Journal for ImmunoTherapy of Cancer - London : BioMed Central, 2013, 1(2013), Suppl 1 vom: 07. Nov.
Übergeordnetes Werk:	volume:1 ; year:2013 ; number:Suppl 1 ; day:07 ; month:11

Links:	Volltext

DOI / URN:	10.1186/2051-1426-1-S1-O6

Katalog-ID:	SPR036421812

Internformat


LEADER	01000caa a22002652 4500
001	SPR036421812
003	DE-627
005	20230519071953.0
007	cr uuu---uuuuu
008	201007s2013 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1186/2051-1426-1-S1-O6 \|2 doi
035			\|a (DE-627)SPR036421812
035			\|a (SPR)2051-1426-1-S1-O6-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
100	1		\|a Callahan, Margaret K \|e verfasserin \|4 aut
245	1	0	\|a Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
264		1	\|c 2013
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Callahan et al; licensee BioMed Central Ltd. 2013
650		4	\|a Ipilimumab \|7 (dpeaa)DE-He213
650		4	\|a Absolute Lymphocyte Count \|7 (dpeaa)DE-He213
650		4	\|a Tumor Immune Evasion \|7 (dpeaa)DE-He213
650		4	\|a Ipilimumab Monotherapy \|7 (dpeaa)DE-He213
650		4	\|a Serial Peripheral Blood \|7 (dpeaa)DE-He213
700	1		\|a Horak, Christine E \|4 aut
700	1		\|a Curran, Michael A \|4 aut
700	1		\|a Hollman, Travis \|4 aut
700	1		\|a Schaer, David A \|4 aut
700	1		\|a Yuan, Jianda \|4 aut
700	1		\|a Lesokhin, Alexander M \|4 aut
700	1		\|a Kitano, Shigehisa \|4 aut
700	1		\|a Hong, Quan \|4 aut
700	1		\|a Ariyan, Charlotte E \|4 aut
700	1		\|a Busam, Klaus J \|4 aut
700	1		\|a Feely, William \|4 aut
700	1		\|a Jure-Kunkel, Maria \|4 aut
700	1		\|a Grosso, Joseph \|4 aut
700	1		\|a Simon, Jason S \|4 aut
700	1		\|a Korman, Alan J \|4 aut
700	1		\|a Wigginton, Jon M \|4 aut
700	1		\|a Gupta, Ashok K \|4 aut
700	1		\|a Zhang, Xiaoling \|4 aut
700	1		\|a Phillips, Therese \|4 aut
700	1		\|a Simmons, Pauline \|4 aut
700	1		\|a Sznol, Mario \|4 aut
700	1		\|a Wolchok, Jedd D \|4 aut
773	0	8	\|i Enthalten in \|t Journal for ImmunoTherapy of Cancer \|d London : BioMed Central, 2013 \|g 1(2013), Suppl 1 vom: 07. Nov. \|w (DE-627)750086335 \|w (DE-600)2719863-7 \|x 2051-1426 \|7 nnns
773	1	8	\|g volume:1 \|g year:2013 \|g number:Suppl 1 \|g day:07 \|g month:11
856	4	0	\|u https://dx.doi.org/10.1186/2051-1426-1-S1-O6 \|z kostenfrei \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_11
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_39
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_63
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_95
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_161
912			\|a GBV_ILN_170
912			\|a GBV_ILN_206
912			\|a GBV_ILN_213
912			\|a GBV_ILN_230
912			\|a GBV_ILN_285
912			\|a GBV_ILN_293
912			\|a GBV_ILN_602
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_4012
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4126
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4367
912			\|a GBV_ILN_4700
951			\|a AR
952			\|d 1 \|j 2013 \|e Suppl 1 \|b 07 \|c 11

Indexfelder

author_variant	m k c mk mkc c e h ce ceh m a c ma mac t h th d a s da das j y jy a m l am aml s k sk q h qh c e a ce cea k j b kj kjb w f wf m j k mjk j g jg j s s js jss a j k aj ajk j m w jm jmw a k g ak akg x z xz t p tp p s ps m s ms j d w jd jdw
matchkey_str	article:20511426:2013----::eihrlloaduoboakriptetwtavnemlnmtetdihobntonvlmbn
hierarchy_sort_str	2013
publishDate	2013
allfields	10.1186/2051-1426-1-S1-O6 doi (DE-627)SPR036421812 (SPR)2051-1426-1-S1-O6-e DE-627 ger DE-627 rakwb eng Callahan, Margaret K verfasserin aut Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Callahan et al; licensee BioMed Central Ltd. 2013 Ipilimumab (dpeaa)DE-He213 Absolute Lymphocyte Count (dpeaa)DE-He213 Tumor Immune Evasion (dpeaa)DE-He213 Ipilimumab Monotherapy (dpeaa)DE-He213 Serial Peripheral Blood (dpeaa)DE-He213 Horak, Christine E aut Curran, Michael A aut Hollman, Travis aut Schaer, David A aut Yuan, Jianda aut Lesokhin, Alexander M aut Kitano, Shigehisa aut Hong, Quan aut Ariyan, Charlotte E aut Busam, Klaus J aut Feely, William aut Jure-Kunkel, Maria aut Grosso, Joseph aut Simon, Jason S aut Korman, Alan J aut Wigginton, Jon M aut Gupta, Ashok K aut Zhang, Xiaoling aut Phillips, Therese aut Simmons, Pauline aut Sznol, Mario aut Wolchok, Jedd D aut Enthalten in Journal for ImmunoTherapy of Cancer London : BioMed Central, 2013 1(2013), Suppl 1 vom: 07. Nov. (DE-627)750086335 (DE-600)2719863-7 2051-1426 nnns volume:1 year:2013 number:Suppl 1 day:07 month:11 https://dx.doi.org/10.1186/2051-1426-1-S1-O6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 1 2013 Suppl 1 07 11
spelling	10.1186/2051-1426-1-S1-O6 doi (DE-627)SPR036421812 (SPR)2051-1426-1-S1-O6-e DE-627 ger DE-627 rakwb eng Callahan, Margaret K verfasserin aut Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Callahan et al; licensee BioMed Central Ltd. 2013 Ipilimumab (dpeaa)DE-He213 Absolute Lymphocyte Count (dpeaa)DE-He213 Tumor Immune Evasion (dpeaa)DE-He213 Ipilimumab Monotherapy (dpeaa)DE-He213 Serial Peripheral Blood (dpeaa)DE-He213 Horak, Christine E aut Curran, Michael A aut Hollman, Travis aut Schaer, David A aut Yuan, Jianda aut Lesokhin, Alexander M aut Kitano, Shigehisa aut Hong, Quan aut Ariyan, Charlotte E aut Busam, Klaus J aut Feely, William aut Jure-Kunkel, Maria aut Grosso, Joseph aut Simon, Jason S aut Korman, Alan J aut Wigginton, Jon M aut Gupta, Ashok K aut Zhang, Xiaoling aut Phillips, Therese aut Simmons, Pauline aut Sznol, Mario aut Wolchok, Jedd D aut Enthalten in Journal for ImmunoTherapy of Cancer London : BioMed Central, 2013 1(2013), Suppl 1 vom: 07. Nov. (DE-627)750086335 (DE-600)2719863-7 2051-1426 nnns volume:1 year:2013 number:Suppl 1 day:07 month:11 https://dx.doi.org/10.1186/2051-1426-1-S1-O6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 1 2013 Suppl 1 07 11
allfields_unstemmed	10.1186/2051-1426-1-S1-O6 doi (DE-627)SPR036421812 (SPR)2051-1426-1-S1-O6-e DE-627 ger DE-627 rakwb eng Callahan, Margaret K verfasserin aut Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Callahan et al; licensee BioMed Central Ltd. 2013 Ipilimumab (dpeaa)DE-He213 Absolute Lymphocyte Count (dpeaa)DE-He213 Tumor Immune Evasion (dpeaa)DE-He213 Ipilimumab Monotherapy (dpeaa)DE-He213 Serial Peripheral Blood (dpeaa)DE-He213 Horak, Christine E aut Curran, Michael A aut Hollman, Travis aut Schaer, David A aut Yuan, Jianda aut Lesokhin, Alexander M aut Kitano, Shigehisa aut Hong, Quan aut Ariyan, Charlotte E aut Busam, Klaus J aut Feely, William aut Jure-Kunkel, Maria aut Grosso, Joseph aut Simon, Jason S aut Korman, Alan J aut Wigginton, Jon M aut Gupta, Ashok K aut Zhang, Xiaoling aut Phillips, Therese aut Simmons, Pauline aut Sznol, Mario aut Wolchok, Jedd D aut Enthalten in Journal for ImmunoTherapy of Cancer London : BioMed Central, 2013 1(2013), Suppl 1 vom: 07. Nov. (DE-627)750086335 (DE-600)2719863-7 2051-1426 nnns volume:1 year:2013 number:Suppl 1 day:07 month:11 https://dx.doi.org/10.1186/2051-1426-1-S1-O6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 1 2013 Suppl 1 07 11
allfieldsGer	10.1186/2051-1426-1-S1-O6 doi (DE-627)SPR036421812 (SPR)2051-1426-1-S1-O6-e DE-627 ger DE-627 rakwb eng Callahan, Margaret K verfasserin aut Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Callahan et al; licensee BioMed Central Ltd. 2013 Ipilimumab (dpeaa)DE-He213 Absolute Lymphocyte Count (dpeaa)DE-He213 Tumor Immune Evasion (dpeaa)DE-He213 Ipilimumab Monotherapy (dpeaa)DE-He213 Serial Peripheral Blood (dpeaa)DE-He213 Horak, Christine E aut Curran, Michael A aut Hollman, Travis aut Schaer, David A aut Yuan, Jianda aut Lesokhin, Alexander M aut Kitano, Shigehisa aut Hong, Quan aut Ariyan, Charlotte E aut Busam, Klaus J aut Feely, William aut Jure-Kunkel, Maria aut Grosso, Joseph aut Simon, Jason S aut Korman, Alan J aut Wigginton, Jon M aut Gupta, Ashok K aut Zhang, Xiaoling aut Phillips, Therese aut Simmons, Pauline aut Sznol, Mario aut Wolchok, Jedd D aut Enthalten in Journal for ImmunoTherapy of Cancer London : BioMed Central, 2013 1(2013), Suppl 1 vom: 07. Nov. (DE-627)750086335 (DE-600)2719863-7 2051-1426 nnns volume:1 year:2013 number:Suppl 1 day:07 month:11 https://dx.doi.org/10.1186/2051-1426-1-S1-O6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 1 2013 Suppl 1 07 11
allfieldsSound	10.1186/2051-1426-1-S1-O6 doi (DE-627)SPR036421812 (SPR)2051-1426-1-S1-O6-e DE-627 ger DE-627 rakwb eng Callahan, Margaret K verfasserin aut Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Callahan et al; licensee BioMed Central Ltd. 2013 Ipilimumab (dpeaa)DE-He213 Absolute Lymphocyte Count (dpeaa)DE-He213 Tumor Immune Evasion (dpeaa)DE-He213 Ipilimumab Monotherapy (dpeaa)DE-He213 Serial Peripheral Blood (dpeaa)DE-He213 Horak, Christine E aut Curran, Michael A aut Hollman, Travis aut Schaer, David A aut Yuan, Jianda aut Lesokhin, Alexander M aut Kitano, Shigehisa aut Hong, Quan aut Ariyan, Charlotte E aut Busam, Klaus J aut Feely, William aut Jure-Kunkel, Maria aut Grosso, Joseph aut Simon, Jason S aut Korman, Alan J aut Wigginton, Jon M aut Gupta, Ashok K aut Zhang, Xiaoling aut Phillips, Therese aut Simmons, Pauline aut Sznol, Mario aut Wolchok, Jedd D aut Enthalten in Journal for ImmunoTherapy of Cancer London : BioMed Central, 2013 1(2013), Suppl 1 vom: 07. Nov. (DE-627)750086335 (DE-600)2719863-7 2051-1426 nnns volume:1 year:2013 number:Suppl 1 day:07 month:11 https://dx.doi.org/10.1186/2051-1426-1-S1-O6 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 1 2013 Suppl 1 07 11
language	English
source	Enthalten in Journal for ImmunoTherapy of Cancer 1(2013), Suppl 1 vom: 07. Nov. volume:1 year:2013 number:Suppl 1 day:07 month:11
sourceStr	Enthalten in Journal for ImmunoTherapy of Cancer 1(2013), Suppl 1 vom: 07. Nov. volume:1 year:2013 number:Suppl 1 day:07 month:11
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Ipilimumab Absolute Lymphocyte Count Tumor Immune Evasion Ipilimumab Monotherapy Serial Peripheral Blood
isfreeaccess_bool	true
container_title	Journal for ImmunoTherapy of Cancer
authorswithroles_txt_mv	Callahan, Margaret K @@aut@@ Horak, Christine E @@aut@@ Curran, Michael A @@aut@@ Hollman, Travis @@aut@@ Schaer, David A @@aut@@ Yuan, Jianda @@aut@@ Lesokhin, Alexander M @@aut@@ Kitano, Shigehisa @@aut@@ Hong, Quan @@aut@@ Ariyan, Charlotte E @@aut@@ Busam, Klaus J @@aut@@ Feely, William @@aut@@ Jure-Kunkel, Maria @@aut@@ Grosso, Joseph @@aut@@ Simon, Jason S @@aut@@ Korman, Alan J @@aut@@ Wigginton, Jon M @@aut@@ Gupta, Ashok K @@aut@@ Zhang, Xiaoling @@aut@@ Phillips, Therese @@aut@@ Simmons, Pauline @@aut@@ Sznol, Mario @@aut@@ Wolchok, Jedd D @@aut@@
publishDateDaySort_date	2013-11-07T00:00:00Z
hierarchy_top_id	750086335
id	SPR036421812
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036421812</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519071953.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/2051-1426-1-S1-O6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036421812</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)2051-1426-1-S1-O6-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Callahan, Margaret K</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Callahan et al; licensee BioMed Central Ltd. 2013</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ipilimumab</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Absolute Lymphocyte Count</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor Immune Evasion</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ipilimumab Monotherapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Serial Peripheral Blood</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Horak, Christine E</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Curran, Michael A</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hollman, Travis</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schaer, David A</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yuan, Jianda</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lesokhin, Alexander M</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kitano, Shigehisa</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hong, Quan</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ariyan, Charlotte E</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Busam, Klaus J</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Feely, William</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jure-Kunkel, Maria</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grosso, Joseph</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simon, Jason S</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Korman, Alan J</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wigginton, Jon M</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gupta, Ashok K</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Xiaoling</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Phillips, Therese</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simmons, Pauline</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sznol, Mario</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wolchok, Jedd D</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Journal for ImmunoTherapy of Cancer</subfield><subfield code="d">London : BioMed Central, 2013</subfield><subfield code="g">1(2013), Suppl 1 vom: 07. Nov.</subfield><subfield code="w">(DE-627)750086335</subfield><subfield code="w">(DE-600)2719863-7</subfield><subfield code="x">2051-1426</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:Suppl 1</subfield><subfield code="g">day:07</subfield><subfield code="g">month:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/2051-1426-1-S1-O6</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">2013</subfield><subfield code="e">Suppl 1</subfield><subfield code="b">07</subfield><subfield code="c">11</subfield></datafield></record></collection>
author	Callahan, Margaret K
spellingShingle	Callahan, Margaret K misc Ipilimumab misc Absolute Lymphocyte Count misc Tumor Immune Evasion misc Ipilimumab Monotherapy misc Serial Peripheral Blood Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
authorStr	Callahan, Margaret K
ppnlink_with_tag_str_mv	@@773@@(DE-627)750086335
format	electronic Article
delete_txt_mv	keep
author_role	aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut aut
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2051-1426
topic_title	Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab Ipilimumab (dpeaa)DE-He213 Absolute Lymphocyte Count (dpeaa)DE-He213 Tumor Immune Evasion (dpeaa)DE-He213 Ipilimumab Monotherapy (dpeaa)DE-He213 Serial Peripheral Blood (dpeaa)DE-He213
topic	misc Ipilimumab misc Absolute Lymphocyte Count misc Tumor Immune Evasion misc Ipilimumab Monotherapy misc Serial Peripheral Blood
topic_unstemmed	misc Ipilimumab misc Absolute Lymphocyte Count misc Tumor Immune Evasion misc Ipilimumab Monotherapy misc Serial Peripheral Blood
topic_browse	misc Ipilimumab misc Absolute Lymphocyte Count misc Tumor Immune Evasion misc Ipilimumab Monotherapy misc Serial Peripheral Blood
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Journal for ImmunoTherapy of Cancer
hierarchy_parent_id	750086335
hierarchy_top_title	Journal for ImmunoTherapy of Cancer
isfreeaccess_txt	true
familylinks_str_mv	(DE-627)750086335 (DE-600)2719863-7
title	Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
ctrlnum	(DE-627)SPR036421812 (SPR)2051-1426-1-S1-O6-e
title_full	Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
author_sort	Callahan, Margaret K
journal	Journal for ImmunoTherapy of Cancer
journalStr	Journal for ImmunoTherapy of Cancer
lang_code	eng
isOA_bool	true
recordtype	marc
publishDateSort	2013
contenttype_str_mv	txt
author_browse	Callahan, Margaret K Horak, Christine E Curran, Michael A Hollman, Travis Schaer, David A Yuan, Jianda Lesokhin, Alexander M Kitano, Shigehisa Hong, Quan Ariyan, Charlotte E Busam, Klaus J Feely, William Jure-Kunkel, Maria Grosso, Joseph Simon, Jason S Korman, Alan J Wigginton, Jon M Gupta, Ashok K Zhang, Xiaoling Phillips, Therese Simmons, Pauline Sznol, Mario Wolchok, Jedd D
container_volume	1
format_se	Elektronische Aufsätze
author-letter	Callahan, Margaret K
doi_str_mv	10.1186/2051-1426-1-S1-O6
title_sort	peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-pd-1, bms-936558, ono-4538) and ipilimumab
title_auth	Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
abstract	© Callahan et al; licensee BioMed Central Ltd. 2013
abstractGer	© Callahan et al; licensee BioMed Central Ltd. 2013
abstract_unstemmed	© Callahan et al; licensee BioMed Central Ltd. 2013
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2014 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700
container_issue	Suppl 1
title_short	Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab
url	https://dx.doi.org/10.1186/2051-1426-1-S1-O6
remote_bool	true
author2	Horak, Christine E Curran, Michael A Hollman, Travis Schaer, David A Yuan, Jianda Lesokhin, Alexander M Kitano, Shigehisa Hong, Quan Ariyan, Charlotte E Busam, Klaus J Feely, William Jure-Kunkel, Maria Grosso, Joseph Simon, Jason S Korman, Alan J Wigginton, Jon M Gupta, Ashok K Zhang, Xiaoling Phillips, Therese Simmons, Pauline Sznol, Mario Wolchok, Jedd D
author2Str	Horak, Christine E Curran, Michael A Hollman, Travis Schaer, David A Yuan, Jianda Lesokhin, Alexander M Kitano, Shigehisa Hong, Quan Ariyan, Charlotte E Busam, Klaus J Feely, William Jure-Kunkel, Maria Grosso, Joseph Simon, Jason S Korman, Alan J Wigginton, Jon M Gupta, Ashok K Zhang, Xiaoling Phillips, Therese Simmons, Pauline Sznol, Mario Wolchok, Jedd D
ppnlink	750086335
mediatype_str_mv	c
isOA_txt	true
hochschulschrift_bool	false
doi_str	10.1186/2051-1426-1-S1-O6
up_date	2024-07-03T17:31:38.971Z
_version_	1803579974196658176
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036421812</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519071953.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/2051-1426-1-S1-O6</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036421812</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)2051-1426-1-S1-O6-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Callahan, Margaret K</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Callahan et al; licensee BioMed Central Ltd. 2013</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ipilimumab</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Absolute Lymphocyte Count</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Tumor Immune Evasion</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ipilimumab Monotherapy</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Serial Peripheral Blood</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Horak, Christine E</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Curran, Michael A</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hollman, Travis</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schaer, David A</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Yuan, Jianda</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lesokhin, Alexander M</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kitano, Shigehisa</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hong, Quan</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ariyan, Charlotte E</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Busam, Klaus J</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Feely, William</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jure-Kunkel, Maria</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Grosso, Joseph</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simon, Jason S</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Korman, Alan J</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wigginton, Jon M</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gupta, Ashok K</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Xiaoling</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Phillips, Therese</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Simmons, Pauline</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sznol, Mario</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wolchok, Jedd D</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Journal for ImmunoTherapy of Cancer</subfield><subfield code="d">London : BioMed Central, 2013</subfield><subfield code="g">1(2013), Suppl 1 vom: 07. Nov.</subfield><subfield code="w">(DE-627)750086335</subfield><subfield code="w">(DE-600)2719863-7</subfield><subfield code="x">2051-1426</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:Suppl 1</subfield><subfield code="g">day:07</subfield><subfield code="g">month:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/2051-1426-1-S1-O6</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1</subfield><subfield code="j">2013</subfield><subfield code="e">Suppl 1</subfield><subfield code="b">07</subfield><subfield code="c">11</subfield></datafield></record></collection>
score	7.40189

Nicht das Richtige dabei?

Schreiben Sie uns!

Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?